DekaBank Deutsche Girozentrale Has $18.93 Million Stock Position in Axon Enterprise, Inc $AXON

DekaBank Deutsche Girozentrale lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 34.3% in the second quarter, Holdings Channel.com reports. The institutional investor owned 22,812 shares of the biotechnology company’s stock after acquiring an additional 5,826 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Axon Enterprise were worth $18,933,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of AXON. Brighton Jones LLC bought a new stake in Axon Enterprise during the 4th quarter worth $480,000. GAMMA Investing LLC raised its stake in Axon Enterprise by 11.8% during the 1st quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company’s stock worth $765,000 after buying an additional 154 shares during the period. Blue Trust Inc. raised its stake in Axon Enterprise by 33.1% during the 1st quarter. Blue Trust Inc. now owns 169 shares of the biotechnology company’s stock worth $89,000 after buying an additional 42 shares during the period. Flagship Harbor Advisors LLC raised its stake in shares of Axon Enterprise by 2.0% in the first quarter. Flagship Harbor Advisors LLC now owns 1,863 shares of the biotechnology company’s stock worth $980,000 after purchasing an additional 37 shares during the last quarter. Finally, XML Financial LLC purchased a new stake in shares of Axon Enterprise in the first quarter worth approximately $229,000. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CAO Jennifer H. Mak sold 77 shares of the firm’s stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $760.00, for a total transaction of $58,520.00. Following the sale, the chief accounting officer owned 15,003 shares in the company, valued at $11,402,280. This trade represents a 0.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $713.74, for a total value of $7,137,400.00. Following the sale, the chief executive officer owned 3,033,982 shares in the company, valued at $2,165,474,312.68. The trade was a 0.33% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 59,932 shares of company stock valued at $45,115,616. 4.40% of the stock is currently owned by company insiders.

Axon Enterprise Trading Down 0.8%

Shares of AXON stock opened at $701.09 on Thursday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. Axon Enterprise, Inc has a 52-week low of $422.38 and a 52-week high of $885.91. The company has a market capitalization of $55.04 billion, a PE ratio of 173.11, a price-to-earnings-growth ratio of 27.46 and a beta of 1.41. The business’s fifty day moving average is $734.21 and its 200 day moving average is $720.68.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. During the same quarter last year, the business posted $1.20 earnings per share. The firm’s revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analyst Ratings Changes

AXON has been the subject of several recent analyst reports. Wolfe Research initiated coverage on Axon Enterprise in a report on Monday, July 7th. They issued an “outperform” rating for the company. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. JMP Securities reissued a “market outperform” rating and set a $825.00 price objective on shares of Axon Enterprise in a report on Monday, September 29th. Bank of America increased their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Axon Enterprise in a report on Wednesday, October 8th. Fourteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $841.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.